Authors: Eglen, RM Choppin, A Watson, N

Citation: Rm. Eglen et al., Therapeutic, opportunities from muscarinic receptor research, TRENDS PHAR, 22(8), 2001, pp. 409-414

Authors: Choppin, A Blue, DR Hegde, SS Gennevois, D McKinnon, SA Mokatrin, A Bivalacqua, TJ Hellstrom, WJG

Citation: A. Choppin et al., Evaluation of oral Ro70-0004/003, an alpha(1A)-adrenoceptor antagonist, inthe treatment of male erectile dysfunction, INT J IMPOT, 13(3), 2001, pp. 157-161

Authors: Choppin, A Eglen, RM

Citation: A. Choppin et Rm. Eglen, Pharmacological characterization of muscarinic receptors in mouse isolatedurinary bladder smooth muscle, BR J PHARM, 133(7), 2001, pp. 1035-1040

Authors: Choppin, A Eglen, RM

Citation: A. Choppin et Rm. Eglen, Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle, BR J PHARM, 132(4), 2001, pp. 835-842

Authors: Eglen, RM Choppin, A Dillon, MP Hegde, S

Citation: Rm. Eglen et al., Muscarinic receptor ligands and their therapeutic potential, CURR OP C B, 3(4), 1999, pp. 426-432

Authors: Choppin, A Stepan, GJ Loury, DN Watson, N Eglen, RM

Citation: A. Choppin et al., Characterization of the muscarinic receptor in isolated uterus of sham operated and ovariectomized rats, BR J PHARM, 127(7), 1999, pp. 1551-1558